Panel Backs Requiring Arkansas to Provide Drug

An advisory board recommended that Arkansas’s Medicaid program eliminate curbs on a Vertex Pharmaceuticals cystic-fibrosis drug that costs $311,000 annually per patient



from WSJ.com: US Business http://ift.tt/ZF25Fs

via IFTTT